Basilea Pharmaceutica AG (BSLN) — Cash Flow-to-Debt Ratio
Basilea Pharmaceutica AG (BSLN) has a Cash Flow-to-Debt Ratio of 0.25x as of December 2025, meaning its operating cash flow of CHF39.03 Million could theoretically repay 0% of its total liabilities (CHF154.06 Million) in one year. See Basilea Pharmaceutica AG (BSLN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Basilea Pharmaceutica AG Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Basilea Pharmaceutica AG across 24 annual periods. Also explore BSLN net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Basilea Pharmaceutica AG (2002–2025)
Year-by-year debt coverage analysis for Basilea Pharmaceutica AG. For market capitalisation and broader financial context, see market value of Basilea Pharmaceutica AG.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.40x | CHF62.09 Million | CHF154.06 Million | ▼ -4.2% |
| 2024 | 0.42x | CHF74.36 Million | CHF176.76 Million | ▲ +441.3% |
| 2023 | 0.08x | CHF14.24 Million | CHF183.29 Million | ▲ +166.1% |
| 2022 | 0.03x | CHF7.06 Million | CHF241.56 Million | ▲ +127.9% |
| 2021 | -0.10x | CHF-32.02 Million | CHF305.87 Million | ▲ +35.8% |
| 2020 | -0.16x | CHF-54.13 Million | CHF331.84 Million | ▲ +19.6% |
| 2019 | -0.20x | CHF-63.84 Million | CHF314.43 Million | ▲ +10.7% |
| 2018 | -0.23x | CHF-79.21 Million | CHF348.44 Million | ▼ -569.4% |
| 2017 | 0.05x | CHF19.01 Million | CHF392.61 Million | ▲ +123.4% |
| 2016 | -0.21x | CHF-75.00 Million | CHF362.76 Million | ▼ -17.1% |
| 2015 | -0.18x | CHF-67.78 Million | CHF383.88 Million | ▲ +50.7% |
| 2014 | -0.36x | CHF-71.46 Million | CHF199.45 Million | ▼ -37.9% |
| 2013 | -0.26x | CHF-59.47 Million | CHF228.88 Million | ▼ -147.3% |
| 2012 | 0.55x | CHF148.17 Million | CHF269.84 Million | ▲ +155.9% |
| 2011 | -0.98x | CHF-82.38 Million | CHF83.82 Million | ▼ -198.0% |
| 2010 | 1.00x | CHF106.64 Million | CHF106.30 Million | ▲ +195.4% |
| 2009 | -1.05x | CHF-114.51 Million | CHF108.88 Million | ▼ -6.2% |
| 2008 | -0.99x | CHF-127.17 Million | CHF128.38 Million | ▼ -58.4% |
| 2007 | -0.63x | CHF-78.99 Million | CHF126.34 Million | ▲ +21.7% |
| 2006 | -0.80x | CHF-72.47 Million | CHF90.78 Million | ▼ -303.6% |
| 2005 | 0.39x | CHF34.38 Million | CHF87.69 Million | ▲ +112.9% |
| 2004 | -3.03x | CHF-64.20 Million | CHF21.18 Million | ▲ +3.3% |
| 2003 | -3.13x | CHF-52.42 Million | CHF16.73 Million | ▼ -22.9% |
| 2002 | -2.55x | CHF-64.07 Million | CHF25.13 Million | — |